Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | PRKDC | P78527 | 7/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 3/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.38 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.38 |
| ▸ | PIK3CG | P48736 | 3/20 | 0.38 |
| ▸ | BRD4 | O60885 | 2/20 | 0.38 |
| ▸ | BRD2 | P25440 | 2/20 | 0.38 |
| ▸ | BRD3 | Q15059 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | PDE2A | O00408 | 1/20 | 0.38 |
| ▸ | PIK3C2A | O00443 | 1/20 | 0.38 |
| ▸ | PIK3R2 | O00459 | 1/20 | 0.38 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10038519 | 0.97 | KDM4E (0.51) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL15988960 | 0.96 | KDM4E (0.45) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL10165773 | 0.96 | KDM4E (0.47) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL13829570 | 0.96 | KDM4E (0.44) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL15988940 | 0.96 | KDM4E (0.47) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL1635727 | 0.95 | KDM4E (0.49) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL17885352 | 0.93 | KDM4E (0.44) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL14039033 | 0.93 | KDM4E (0.42) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL16441411 | 0.93 | KDM4E (0.42) | KDM4EL3MBTL1ATMALOX5PRKDC | |
| SCHEMBL780958 | 0.92 | KDM4E (0.41) | KDM4EL3MBTL1ATMALOX5PRKDC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9133173-B2 | Carbazole compound, material for light-emitting element, organic semiconductor material, light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-9133173-B2 | Carbazole compound, material for light-emitting element, organic semiconductor material, light-emitting element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-04-19 | — | — | US | disclosed |
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120091887-A1 | Carbazole Compound, Material for Light-Emitting Element, Organic Semiconductor Material, Light-Emitting Element | NUTF2, BRI3BP, CLINT1 | KDM4E 2172/4885L3MBTL1 1016/4885ATM 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.